| Literature DB >> 21829278 |
Sudheer Deshpande1, H R Nagendra, Nagarathna Raghuram.
Abstract
OBJECTIVE: To study the efficacy of yoga on Guna (yogic personality measure) and general health in normal adults.Entities:
Keywords: General health; Yoga; guna
Year: 2008 PMID: 21829278 PMCID: PMC3144604 DOI: 10.4103/0973-6131.36785
Source DB: PubMed Journal: Int J Yoga ISSN: 0973-6131

Comparison between our data and Vpi data
Demographic data for VPI
| Age | Sex | Y ( | PE ( |
|---|---|---|---|
| ≤ 24 years (Juniors) | Male (m±SD) | 26.79±12.20 | 28.00±11.76 |
| Female (m±SD) | 20.00±1.75 | 20.29±1.44 | |
| > 24 years (Seniors) | Male (m±SD) | 20.61±1.82 | 20.73±1.89 |
| Female (m±SD) | 38.88±9.55 | 30.85±8.56 | |
| Gender | Male (m±SD) | 41.36±13.89 | 40.82±10.85 |
| Range | 18–71 | 18–58 | |
| Female | 40 | 40 | |
| Categories | Male | 47 | 47 |
| Students | 49 | 44 | |
| Employees | 18 | 30 | |
| Housewives | 10 | 7 | |
| Business | 10 | 6 |
VPI scores for yoga and control groups—comparison of means (paired samples test)
| Before Means±SD Y | After Means±SD Y | Effect Size | Before Means±SD PE | After Means±SD PE | Effect Size | |||
|---|---|---|---|---|---|---|---|---|
| 3.12 ± 0.51 | 2.97 ± 0.91 | 0.095 | 0.18 | 3.24 ± 0.67 | 2.99 ± 0.69 | 0.001 | 0.36 | |
| 3.83 ± 0.62 | 3.72 ± 0.51 | 0.12 | 0.17 | 3.67 ± 0.62 | 3.43 ± 0.79 | 0.002 | 0.33 | |
| 4.88 ± 0.52 | 5.26 ± 0.51 | <0.001 | 0.61 | 4.91 ± 0.53 | 5.21 ± 0.65 | <0.001 | 0.45 |
Rajas showed a significant difference between the groups (P = 0.005) (Independent Samples Test); (Effect size = difference in means (after–before)/SD of the difference scores)
GHQ scores (Wilcoxon signed ranks test)
| Before Means±SD Y | After Means±SD Y | Before Means±SD PE | After Means±SD PE | |||
|---|---|---|---|---|---|---|
| SS | 0.57 ± 0.91 | 0.29 ± 0.65 | <0.001 | 0.41 ± 0.80 | 0.11 ± 0.32 | 0.001 |
| AI | 0.61 ± 0.92 | 0.08 ± 0.38 | <0.001 | 0.49 ± 0.90 | 0.18 ± 0.74 | 0.011 |
| SF | 0.60 ± 0.91 | 0.15 ± 0.39 | <0.001 | 0.60 ± 0.99 | 0.23 ± 0.52 | 0.001 |
| SP | 0.44 ± 0.73 | 0.22 ± 0.58 | 0.017 | 0.52 ± 0.65 | 0.15 ± 0.42 | <0.001 |
| TH | 2.22 ± 2.48 | 0.74 ± 1.21 | <0.001 | 2.02 ± 2.78 | 0.68 ± 1.28 | <0.001 |
SS: Somatic symptoms; AI: Anxiety and insomnia; SF: Social dysfunction; SP: Severe depression; TH: Total health
VPI scores in age groups - Age ≤ 24 years and > 24 years (paired-samples t test)
| Before Means±SD Y | After Means±SD Y | Before Means±SD PE | After Means±SD PE | ||||
|---|---|---|---|---|---|---|---|
| Age ≤ 24 years | 3.16 ± 0.49 | 3.20 ± 1.63 | 0.774 | 3.28 ± 0.67 | 3.16 ± 2.13 | 0.4 | |
| 3.84 ± 0.66 | 3.99 ± 0.74 | 0.286 | 3.75 ± 0.63 | 3.56 ± 0.75 | 0.152 | ||
| 4.67 ± 0.47 | 5.26 ± 0.55 | <0.001 | 4.79 ± 0.44 | 5.14 ± 0.65 | 0.002 | ||
| Age > 24 years | 3.09 ± 0.53 | 2.67 ± 0.69 | 0.001 | 3.21 ± 0.68 | 2.83 ± 0.77 | 0.001 | |
| 3.81 ± 0.61 | 3.51 ± 0.57 | 0.002 | 3.62 ± 0.62 | 3.31 ± 0.83 | 0.015 | ||
| 4.91 ± 0.59 | 5.12 ± 0.45 | 0.001 | 5.00 ± 0.59 | 5.09 ± 0.62 | 0.014 |
Gender-based VPI scores (paired samples t test)
| Before Means±SD Y | After Means±SD Y | Before Means±SD PE | After Means±SD PE | ||||
|---|---|---|---|---|---|---|---|
| Females | 3.15 ± 0.52 | 2.80 ± 1.04 | 0.04 | 3.20 ± 0.71 | 2.97 ± 0.71 | 0.053 | |
| 3.66 ± 0.62 | 3.43 ± 0.48 | 0.502 | 3.64 ± 0.63 | 3.50 ± 0.80 | 0.196 | ||
| 4.91 ± 0.42 | 5.20 ± 0.50 | 0.004 | 4.98 ± 0.58 | 5.23 ± 0.62 | 0.034 | ||
| Males | 3.11 ± 0.50 | 3.10 ± 0.58 | 0.924 | 3.28 ± 0.65 | 3.01 ± 0.46 | 0.032 | |
| 3.96 ± 0.63 | 3.96 ± 0.41 | 0.898 | 3.73 ± 0.63 | 3.50 ± 0.79 | 0.014 | ||
| 4.86 ± 0.60 | 5.33 ± 0.52 | <0.001 | 4.80 ± 0.49 | 5.19 ± 0.68 | 0.001 |
GHQ scores: Age ≤ 24 years and > 24 years (Wilcoxon signed ranks test)
| Before Means±SD Y | After Means±SD Y | Before Means±SD PE | After Means±SD PE | ||||
|---|---|---|---|---|---|---|---|
| Age ≤ 24 years | SS | 0.65 ± 0.93 | 0.43 ± 0.76 | 0.161 | 0.43 ± 0.76 | 0.14 ± 0.35 | 0.01 |
| AI | 0.71 ± 0.96 | 0.10 ± 0.47 | <0.001 | 0.66 ± 0.99 | 0.30 ± 1.00 | 0.057 | |
| SF | 0.80 ± 0.98 | 0.18 ± 0.44 | <0.001 | 0.75 ± 1012 | 0.34 ± 0.64 | 0.019 | |
| SP | 0.45 ± 0.71 | 0.29 ± 0.68 | 0.185 | 0.64 ± 0.89 | 0.16 ± 0.43 | <0.001 | |
| TH | 2.61 ± 2.54 | 1.00 ± 1.44 | <0.001 | 2.48 ± 3.11 | 0.93 ± 1.53 | 0.001 | |
| Age > 24 years | SS | 0.47 ± 0.89 | 0.11 ± 0.39 | 0.004 | 0.40 ± 0.85 | 0.09 ± 0.29 | 0.044 |
| AI | 0.47 ± 0.86 | 0.05 ± 0.23 | 0.002 | 0.33 ± 0.78 | 0.06 ± 0.26 | 0.047 | |
| SF | 0.34 ± 0.75 | 0.11 ± 0.31 | 0.071 | 0.44 ± 0.83 | 0.12 ± 0.32 | 0.017 | |
| SP | 0.42 ± 0.76 | 0.13 ± 0.41 | 0.047 | 0.40 ± 0.79 | 0.14 ± 0.41 | 0.013 | |
| TH | 1.71 ± 2.25 | 0.39 ± 1.00 | 0.001 | 1.56 ± 2.00 | 0.42 ± 0.00 | 0.003 |
SS: Somatic symptoms; AI: Anxiety and insomnia; SF: Social dysfunction; SP: Severe depression; TH: Total health
Gender-based GHQ scores (Wilcoxon signed ranks test)
| Before Means±SD Y | After Means±SD Y | Before Means±SD PE | After Means±SD PE | ||||
|---|---|---|---|---|---|---|---|
| Females | SS | 0.50 ± 0.99 | 0.25 ± 0.58 | 0.115 | 0.40 ± 0.74 | 0.07± 0.27 | 0.018 |
| AI | 0.50 ± 0.85 | 0.02± 0.16 | 0.001 | 0.57 ± 0.98 | 0.30 ± 1.04 | 0.208 | |
| SF | 0.40 ± 0.81 | 0.10 ± 0.30 | 0.038 | 0.45 ± 0.81 | 0.15 ± 0.36 | 0.038 | |
| SP | 0.35 ± 0.62 | 0.28 ± 0.72 | 0.584 | 0.50 ± 0.85 | 0.10 ± 0.45 | 0.005 | |
| TH | 1.71 ± 2.35 | 0.65 ± 1.03 | 0.01 | 1.93 ± 2.80 | 0.70 ± 1.44 | 0.018 | |
| Males | SS | 0.64 ± 0.85 | 0.32 ± 0.69 | 0.027 | 0.43 ± 0.85 | 0.15± 0.36 | 0.022 |
| AI | 0.70 ± 0.98 | 0.13± 0.49 | <0.001 | 0.43 ± 0.83 | 0.08± 0.28 | 0.007 | |
| SF | 0.77 ± 0.96 | 0.19 ± 0.45 | <0.001 | 0.72 ± 1.12 | 0.30 ± 0.62 | 0.009 | |
| SP | 0.51 ± 0.80 | 0.17 ± 0.43 | 0.008 | 0.53 ± 0.86 | 0.13 ± 0.40 | <0.001 | |
| TH | 2.62 ± 2.53 | 0.81 ± 1.36 | <0.001 | 2.11 ± 2.78 | 0.66 ± 1.15 | <0.001 |
SS: Somatic symptoms; AI: Anxiety and insomnia; SF: Social dysfunction; SP: Severe depression; TH: Total health
Comparison between our data (before and after) and standard VPI data
| Observed range | Observed mean±SD | Predicted range | Predicted mean±SD | |||
|---|---|---|---|---|---|---|
| 3.04 - 6.17 | 4.90±0.53 | 3.00 - 6.39 | 4.67±0.75 | |||
| 174 | 2.11 - 5.25 | 3.76±0.63 | 247 | 2.46 - 5.96 | 4.07±1.08 | |
| Tamas | 1.47 - 5.38 | 3.19±0.60 | 1.43 - 6.00 | 3.49±0.90 |